RASP Wealth Solutions’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
RASP Wealth Solutions's LLY Position: Q3 2026 in Review
RASP Wealth Solutions reduced its Eli Lilly (LLY) stake by 23% in Q3 2026, selling an estimated $46.6M and leaving 130,286 shares worth $151M. The position accounts for 59.24% of the portfolio, ranked #1.
RASP Wealth Solutions first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $204M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- RASP Wealth Solutions held 130,286 shares of Eli Lilly worth $151M as of Q3 2026.
- RASP Wealth Solutions sold 39,457 Eli Lilly shares in Q3 2026, an estimated $46.6M.
- Eli Lilly made up 59.24% of RASP Wealth Solutions's portfolio in Q3 2026, its #1 holding.
- RASP Wealth Solutions first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
- RASP Wealth Solutions's Eli Lilly position peaked at $204M in Q2 2026.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on RASP Wealth Solutions's 13F filing for Q3 2026, filed 6 Nov 2026.